UNSW scientists have grown human pancreatic cancer tumours in the lab – their model is the first of its kind, with important future clinical implications.
Four UNSW Sydney researchers have received funding for pioneering work into pancreatic, breast and bone cancers.
This World Pancreatic Cancer Day, we’re highlighting some of the many UNSW Sydney researchers working to improve patient outcomes.
Nanomedicine presentation earns PhD candidate John Kokkinos top prize at UNSW 3MT grand final.
Pancreatic and brain cancer researcher Dr Angelica Merlot has been nominated for 2019 NSW Young Woman of the Year.
UNSW Medicine’s Professor Minoti Apte, OAM has received the Gastroenterological Society of Australia (GESA) Distinguished Researcher Prize 2018.
The Avner Pancreatic Cancer Foundation, Australia’s peak body for the disease, has awarded a second grant to UNSW's Professor Minoti Apte.
Researchers from Sydney's Garvan Institute and the UK have developed a glow-in-the-dark 'biosensor mouse' that offers a real-time readout of the rapidly changing "skeleton" within cells.
A two-step approach has had promising results in the treatment of pancreatic cancer, which has a dismal five-year survival rate of just 7%.
One reason pancreatic cancer has a particularly low survival rate is the difficulty in getting drugs to the tumour, but new knowledge of how pancreatic cancer cells invade neighbouring cells could change that.